CASTLE BIOSCIENCES, INC. Finance Lease, Right-of-Use Asset, Amortization
CASTLE BIOSCIENCES, INC. (CSTL) reported Finance Lease, Right-of-Use Asset, Amortization of $91.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-02-26
- CASTLE BIOSCIENCES, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $91.00K, a 4.60% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $87.00K, a 38.30% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $141.00K, a 9.30% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $129.00K, a 1512.50% increase from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|
| 2025-12-31 | $91.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $87.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $141.00K 10-K · filed 2026-02-26 |
| 2022-12-31 | $129.00K 10-K · filed 2025-02-27 |
| 2021-12-31 | $8.00K 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |